$14.24 0.00 (0%)
2/28/2011 4:03 PM

King Pharmaceuticals, Inc. (NYSE:KG)

CAPS Rating: 2 out of 5

The Company is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products.

Featured Broker Partners


Advertisement